secwatch.observer — SEC 8-K summary
======================================

Issuer:     TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA)
CIK:        0000818686
Form:       8-K
Filed at:   2022-06-23T23:59:59+00:00
Accession:  0001193125-22-180042
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teva shareholders approve amendments to Articles of Association and elect four directors at annual meeting
--------------------------------------------------------------------------------

- Shareholders approved amendments to Articles, effective June 23, 2022, including eliminating minimum in-person board meetings and allowing chairman discretion on meetings in Israel.
- Four directors elected: Amir Elstein, Roberto A. Mignone, Dr. Perry D. Nisen, Dr. Tal Zaks, each to serve until 2025 annual meeting.
- Non-binding advisory vote on executive compensation approved with 424.6M for vs 137.8M against.
- Appointment of Kesselman & Kesselman (PwC) as independent auditor approved.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/818686/000119312522180042/0001193125-22-180042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/818686/000119312522180042/d730888d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-180042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer